galantamine has been researched along with lycoramine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, G; Liu, R; Liu, T; Luo, Z; Wang, J; Xiang, M; Xue, Y; Yao, G; Zhan, G; Zhang, Y; Zhou, J | 1 |
| Huang, J; Liu, J; Liu, R; Yao, G; Zhan, G; Zhang, H; Zhou, J | 1 |
| IRWIN, RL; SMITH, HJ | 1 |
| HSU, B; KIN, KC; TANG, XC | 1 |
| CHAO, JL; CHAO, KC; HU, CC | 1 |
| Malachowski, WP; Paul, T; Phounsavath, S | 1 |
| Ishikawa, T; Kudo, K; Kudoh, T; Kuroyabu, K; Saito, S; Uchida, S | 1 |
| Bao, X; Chen, P; Ding, M; Fan, CA; Han, XJ; Li, J; Tu, YQ; Zhang, GB; Zhang, LF | 1 |
| Bao, DH; Chen, JQ; Liu, S; Xie, JH; Zhou, QL | 1 |
| Katoch, D; Kumar, N; Kumar, S; Singh, B | 1 |
| Chen, N; Dong, Z; Gao, C; Li, Y; Wang, M; Zhang, Y; Zhong, Y; Zhou, J | 1 |
| Feng, Y; Yu, ZX | 1 |
| Jia, Y; Li, L; Wang, Y; Yang, Q | 1 |
| de Andrade, JP; de Souza Borges, W; El Sohafy, SM; Shawky, E | 1 |
| Liu, SZ; Tian, JM; Tu, YQ; Wang, SH; Zhang, CS; Zhang, FM; Zhang, Q; Zhang, XM | 1 |
| Basar, MK; Baykal, AT; Coskun, J; Gurel, B; Kiris, I; Mroczek, T; Sahin, B | 1 |
| Bisai, A; Khatua, A; Majumder, S; Pal, S; Yadav, A | 1 |
17 other study(ies) available for galantamine and lycoramine
| Article | Year |
|---|---|
Galanthamine, Plicamine, and Secoplicamine Alkaloids from Zephyranthes candida and Their Anti-acetylcholinesterase and Anti-inflammatory Activities.
Topics: Acetylcholinesterase; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Crystallography, X-Ray; Drugs, Chinese Herbal; Galantamine; Heterocyclic Compounds, 4 or More Rings; Inhibitory Concentration 50; Liliaceae; Medicine, Traditional; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plants, Medicinal | 2016 |
Acetylcholinesterase Inhibitory Alkaloids from the Whole Plants of Zephyranthes carinata.
Topics: Acetylcholinesterase; Alkaloids; Amaryllidaceae; Amaryllidaceae Alkaloids; Cholinesterase Inhibitors; Heterocyclic Compounds, 4 or More Rings; Inhibitory Concentration 50; Liliaceae; Molecular Structure; Phenanthridines; Structure-Activity Relationship; X-Ray Diffraction | 2017 |
Cholinesterase inhibition by galanthamine and lycoramine.
Topics: Alkaloids; Amaryllidaceae Alkaloids; Cholinesterase Inhibitors; Galantamine | 1960 |
[STUDIES ON THE PHARMACOLOGIC ACTIONS OF THE AMARYLLIDACEAE ALKALOIDS. I. NEUROPHARMACOLOGIC ACTIONS OF LYCORAMINE AND GALANTHAMINE].
Topics: Alkaloids; Amaryllidaceae Alkaloids; Cats; Cholinesterases; Galantamine; Mice; Pharmacology; Rabbits; Research; Toxicology | 1963 |
[THE EFFECT OF GALANTHAMINE AND LYCORAMINE ON THE CHOLINE REACTIVE SYSTEM].
Topics: Alkaloids; Amaryllidaceae Alkaloids; Choline; Galantamine; Parasympathomimetics; Pharmacology; Research | 1965 |
The enantioselective synthesis of (-)-lycoramine with the Birch-Cope sequence.
Topics: Alcohols; Amaryllidaceae Alkaloids; Azepines; Furans; Galantamine; Hydrogen; Molecular Structure; Stereoisomerism | 2007 |
Domino double Michael-Claisen cyclizations: a powerful general tool for introducing quaternary stereocenters at C4 of cyclohexane-1,3-diones and total synthesis of diverse families of sterically congested alkaloids.
Topics: Alkaloids; Amaryllidaceae Alkaloids; Cyclization; Cyclohexanones; Galantamine; Indole Alkaloids; Quinolines; Stereoisomerism | 2008 |
Asymmetric synthesis of bioactive hydrodibenzofuran alkaloids: (-)-lycoramine, (-)-galanthamine, and (+)-lunarine.
Topics: Alkaloids; Amaryllidaceae Alkaloids; Benzofurans; Brassicaceae; Carbon; Catalysis; Cyclization; Galantamine; Liliaceae; Spermidine; Stereoisomerism | 2011 |
Total synthesis of (-)-galanthamine and (-)-lycoramine via catalytic asymmetric hydrogenation and intramolecular reductive Heck cyclization.
Topics: Amaryllidaceae Alkaloids; Catalysis; Cyclization; Galantamine; Hydrogenation; Molecular Structure; Palladium; Ruthenium; Stereoisomerism | 2012 |
Simultaneous quantification of Amaryllidaceae alkaloids from Zephyranthes grandiflora by UPLC-DAD/ESI-MS/MS.
Topics: Amaryllidaceae Alkaloids; Calibration; Chromatography, High Pressure Liquid; Galantamine; Liliaceae; Phenanthridines; Plant Extracts; Pyrroles | 2012 |
[Effect of precursor on growth and accumulation of alkaloids of Lycoris radiata suspension cells].
Topics: Amaryllidaceae Alkaloids; Cells, Cultured; Culture Media; Galantamine; Lycoris; Phenylalanine; Plant Cells; Plant Extracts | 2014 |
Formal synthesis of (±)-galanthamine and (±)-lycoramine using Rh(I)-catalyzed [(3 + 2) + 1] cycloaddition of 1-ene-vinylcyclopropane and CO.
Topics: Amaryllidaceae Alkaloids; Benzofurans; Catalysis; Cycloaddition Reaction; Galantamine; Molecular Structure; Rhodium; Stereoisomerism; Vinyl Compounds | 2015 |
Catalytic asymmetric total synthesis of (-)-galanthamine and (-)-lycoramine.
Topics: Amaryllidaceae Alkaloids; Benzofurans; Biological Products; Catalysis; Galantamine; Palladium; Stereoisomerism | 2015 |
Profiling of acetylcholinesterase inhibitory alkaloids from some
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Amaryllidaceae; Amaryllidaceae Alkaloids; Catalytic Domain; Cholinesterase Inhibitors; Computer Simulation; Crinum; Galantamine; Gas Chromatography-Mass Spectrometry; Humans; Molecular Docking Simulation; Multivariate Analysis; Plant Extracts; Plant Leaves; Plant Roots | 2021 |
Catalytic Asymmetric Total Syntheses of (-)-Galanthamine and (-)-Lycoramine.
Topics: Amaryllidaceae Alkaloids; Catalysis; Galantamine; Molecular Structure; Pyrrolidines; Spiro Compounds; Stereoisomerism | 2019 |
Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer's Disease in Mouse Model.
Topics: Alzheimer Disease; Amaryllidaceae Alkaloids; Amyloid beta-Peptides; Animals; Disease Models, Animal; Galantamine; Mice; Mice, Transgenic | 2021 |
Asymmetric Total Syntheses of (-)-Lycoramine, (-)-Lycoraminone, (-)-Narwedine, and (-)-Galanthamine.
Topics: Amaryllidaceae Alkaloids; Cyclization; Galantamine; Stereoisomerism | 2022 |